Works by Niemi, Mikko

Results: 136
    1

    Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study Open Access.

    Published in:
    European Heart Journal Open, 2025, v. 5, n. 3, p. 1, doi. 10.1093/ehjopen/oeaf046
    By:
    • Luojus, Alex;
    • Lehto, Mika;
    • Halminen, Olli;
    • Lehtonen, Ossi;
    • Niemi, Mikko;
    • Teppo, Konsta;
    • Kuoppala, Jaana;
    • Haukka, Jari;
    • Putaala, Jukka;
    • Linna, Miika;
    • Mustonen, Pirjo;
    • Aro, Aapo;
    • Hartikainen, Juha;
    • Lip, Gregory Yoke Hong;
    • Airaksinen, Kari Eino Juhani
    Publication type:
    Article
    2
    3

    Socio-demographic and genetic risk factors for drug adherence and persistence across 5 common medication classes.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53556-z
    By:
    • Cordioli, Mattia;
    • Corbetta, Andrea;
    • Kariis, Hanna Maria;
    • Jukarainen, Sakari;
    • Vartiainen, Pekka;
    • Kiiskinen, Tuomo;
    • Ferro, Matteo;
    • FinnGen;
    • Perola, Markus;
    • Ripatti, Samuli;
    • Ganna, Andrea;
    • Metspalu, Andres;
    • Milani, Lili;
    • Esko, Tõnu;
    • Mägi, Reedik;
    • Nelis, Mari;
    • Hudjashov, Georgi;
    • Niemi, Mikko;
    • Lehto, Kelli
    Publication type:
    Article
    4
    5
    6

    Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study.

    Published in:
    Annals of Medicine, 2024, v. 56, n. 1, p. 1, doi. 10.1080/07853890.2024.2364825
    By:
    • Lehto, Mika;
    • Luojus, Alex;
    • Halminen, Olli;
    • Haukka, Jari;
    • Putaala, Jukka;
    • Linna, Miika;
    • Mustonen, Pirjo;
    • Kinnunen, Janne;
    • Lehtonen, Ossi;
    • Teppo, Konsta;
    • Tiili, Paula;
    • Kouki, Elis;
    • Itäinen-Strömberg, Saga;
    • Niemi, Mikko;
    • Aro, Aapo L.;
    • Hartikainen, Juha;
    • Juhani Airaksinen, K. E.
    Publication type:
    Article
    7
    8
    9

    Value of Pharmacogenetic Testing Assessed with Real‐World Drug Utilization and Genotype Data.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 278, doi. 10.1002/cpt.3458
    By:
    • Litonius, Kaisa;
    • Kulla, Noora;
    • Falkenbach, Petra;
    • Kristiansson, Kati;
    • Tarkiainen, E. Katriina;
    • Ukkola‐Vuoti, Liisa;
    • Cajanus, Kristiina;
    • Korhonen, Mari;
    • Khan, Sofia;
    • Sistonen, Johanna;
    • Orpana, Arto;
    • Lindstedt, Mats;
    • Nyrönen, Tommi;
    • Perola, Markus;
    • Turpeinen, Miia;
    • Kytö, Ville;
    • Tornio, Aleksi;
    • Niemi, Mikko
    Publication type:
    Article
    10
    11
    12
    13

    PharmVar GeneFocus: SLCO1B1.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 782, doi. 10.1002/cpt.2705
    By:
    • Ramsey, Laura B.;
    • Gong, Li;
    • Lee, Seung‐been;
    • Wagner, Jonathan B.;
    • Zhou, Xujia;
    • Sangkuhl, Katrin;
    • Adams, Solomon M.;
    • Straka, Robert J.;
    • Empey, Philip E.;
    • Boone, Erin C.;
    • Klein, Teri E.;
    • Niemi, Mikko;
    • Gaedigk, Andrea
    Publication type:
    Article
    14

    Genomewide Association Study of Simvastatin Pharmacokinetics.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 676, doi. 10.1002/cpt.2674
    By:
    • Mykkänen, Anssi J. H.;
    • Taskinen, Suvi;
    • Neuvonen, Mikko;
    • Paile‐Hyvärinen, Maria;
    • Tarkiainen, E. Katriina;
    • Lilius, Tuomas;
    • Tapaninen, Tuija;
    • Backman, Janne T.;
    • Tornio, Aleksi;
    • Niemi, Mikko
    Publication type:
    Article
    15

    The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal Symptoms.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 5, p. 1007, doi. 10.1002/cpt.2557
    By:
    • Cooper‐DeHoff, Rhonda M.;
    • Niemi, Mikko;
    • Ramsey, Laura B.;
    • Luzum, Jasmine A.;
    • Tarkiainen, E. Katriina;
    • Straka, Robert J.;
    • Gong, Li;
    • Tuteja, Sony;
    • Wilke, Russell A.;
    • Wadelius, Mia;
    • Larson, Eric A.;
    • Roden, Dan M.;
    • Klein, Teri E.;
    • Yee, Sook Wah;
    • Krauss, Ronald M.;
    • Turner, Richard M.;
    • Palaniappan, Latha;
    • Gaedigk, Andrea;
    • Giacomini, Kathleen M.;
    • Caudle, Kelly E.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Enantiospecific Pharmacogenomics of Fluvastatin.

    Published in:
    Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 3, p. 668, doi. 10.1002/cpt.1463
    By:
    • Hirvensalo, Päivi;
    • Tornio, Aleksi;
    • Neuvonen, Mikko;
    • Kiander, Wilma;
    • Kidron, Heidi;
    • Paile‐Hyvärinen, Maria;
    • Tapaninen, Tuija;
    • Backman, Janne T.;
    • Niemi, Mikko
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer.

    Published in:
    Pediatric Blood & Cancer, 2014, v. 61, n. 5, p. 797, doi. 10.1002/pbc.24921
    By:
    • Levinsen, Mette;
    • Rotevatn, Elisabeth Ørskov;
    • Rosthøj, Susanne;
    • Nersting, Jacob;
    • Abrahamsson, Jonas;
    • Appell, Malin Lindqvist;
    • Bergan, Stein;
    • Bechensteen, Anne‐Grete;
    • Harila‐Saari, Arja;
    • Heyman, Mats;
    • Jonsson, Olafur Gisli;
    • Maxild, Jakob Bernhard Cohn;
    • Niemi, Mikko;
    • Söderhäll, Stefan;
    • Schmiegelow, Kjeld
    Publication type:
    Article
    32

    P562: CAPILLARY BLOOD SAMPLING ALLOWS FEASIBLE METHOD FOR VENETOCLAX CONCENTRATION MEASUREMENT IN AN ACADEMIC MULTICENTER CLINICAL TRIAL CONTEXT.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969152.53119.c1
    By:
    • Kytölä, Sari;
    • Vänttinen, Ida;
    • Kuusanmäki, Heikki;
    • Ruokoranta, Tanja;
    • Kurkela, Mika;
    • Kiiski, Johanna;
    • Holopainen, Annasofia;
    • Partanen, Anu;
    • Kuusisto, Milla E.L.;
    • Koskela, Sirpa;
    • Räty, Riikka;
    • Itälä‐Remes, Maija;
    • Ettala, Pia;
    • Rimpiläinen, Johanna;
    • Siitonen, Timo;
    • Pyörälä, Marja;
    • T. Backman, Janne;
    • Niemi, Mikko;
    • Kontro, Mika
    Publication type:
    Article
    33

    Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study .

    Published in:
    Pharmacology Research & Perspectives, 2022, v. 10, n. 3, p. 1, doi. 10.1002/prp2.961
    By:
    • Teppo, Konsta;
    • Jaakkola, Jussi;
    • Biancari, Fausto;
    • Halminen, Olli;
    • Linna, Miika;
    • Haukka, Jari;
    • Putaala, Jukka;
    • Tiili, Paula;
    • Lehtonen, Ossi;
    • Niemi, Mikko;
    • Mustonen, Pirjo;
    • Kinnunen, Janne;
    • Hartikainen, Juha;
    • Juhani Airaksinen, K. E.;
    • Lehto, Mika
    Publication type:
    Article
    34
    35
    36

    Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.

    Published in:
    Human Genomics, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s40246-024-00579-8
    By:
    • Kiiski, Johanna I.;
    • Neuvonen, Mikko;
    • Kurkela, Mika;
    • Hirvensalo, Päivi;
    • Hämäläinen, Kreetta;
    • Tarkiainen, E. Katriina;
    • Sistonen, Johanna;
    • Korhonen, Mari;
    • Khan, Sofia;
    • Orpana, Arto;
    • Filppula, Anne M.;
    • Lehtonen, Marko;
    • Niemi, Mikko
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    Effect of grapefruit juice on the bioactivation of prasugrel.

    Published in:
    British Journal of Clinical Pharmacology, 2015, v. 80, n. 1, p. 139, doi. 10.1111/bcp.12581
    By:
    • Holmberg, Mikko T.;
    • Tornio, Aleksi;
    • Hyvärinen, Hanna;
    • Neuvonen, Mikko;
    • Neuvonen, Pertti J.;
    • Backman, Janne T.;
    • Niemi, Mikko
    Publication type:
    Article
    45

    Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.

    Published in:
    PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190272
    By:
    • Bastiaens, Guido J. H.;
    • Tiono, Alfred B.;
    • Okebe, Joseph;
    • Pett, Helmi E.;
    • Coulibaly, Sam A.;
    • Gonçalves, Bronner P.;
    • Affara, Muna;
    • Ouédraogo, Alphonse;
    • Bougouma, Edith C.;
    • Sanou, Guillaume S.;
    • Nébié, Issa;
    • Bradley, John;
    • Lanke, Kjerstin H. W.;
    • Niemi, Mikko;
    • Sirima, Sodiomon B.;
    • d’Alessandro, Umberto;
    • Bousema, Teun;
    • Drakeley, Chris
    Publication type:
    Article
    46
    47
    48
    49
    50